🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these profiles directly for source information, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Service Response and Content Removal

Based on the social media company, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The company stated it was committed to keeping the platform secure and investing in strengthening compliance measures.

Online Trading Activities

Investigations also discovered communities with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of weight loss, positive reviews and detailed guides for preparing or injecting at residence.

Within minutes of joining one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Information and Pricing

Inside these groups, posts display dark colored packages with Royal Mail labels, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for Telegram said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the science behind retatrutide is valid, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.